vs

Side-by-side financial comparison of Connect Biopharma Holdings Ltd (CNTB) and MITEK SYSTEMS INC (MITK). Click either name above to swap in a different company.

MITEK SYSTEMS INC is the larger business by last-quarter revenue ($44.2M vs $24.1M, roughly 1.8× Connect Biopharma Holdings Ltd). Connect Biopharma Holdings Ltd runs the higher net margin — 61.6% vs 6.3%, a 55.3% gap on every dollar of revenue.

Connect Biopharma Holdings Ltd is a clinical-stage global biopharmaceutical company dedicated to developing innovative targeted therapies for inflammatory, immunological and autoimmune diseases. Its core pipeline includes candidate treatments for asthma, atopic dermatitis and other conditions with high unmet medical needs, with main operations across the U.S., China and key global markets to deliver effective therapeutic solutions to patients.

Mitek Systems, Inc. is a software company that specializes in digital identity verification and mobile image processing using artificial intelligence. The company's software is used for depositing checks and opening bank accounts via mobile devices. It also verifies identity documents such as passports, ID cards, and driver's licenses by analyzing a selfie of an individual holding their ID, comparing their face to the photo on the document.

CNTB vs MITK — Head-to-Head

Bigger by revenue
MITK
MITK
1.8× larger
MITK
$44.2M
$24.1M
CNTB
Higher net margin
CNTB
CNTB
55.3% more per $
CNTB
61.6%
6.3%
MITK

Income Statement — Q2 FY2024 vs Q1 FY2026

Metric
CNTB
CNTB
MITK
MITK
Revenue
$24.1M
$44.2M
Net Profit
$14.8M
$2.8M
Gross Margin
Operating Margin
56.6%
12.3%
Net Margin
61.6%
6.3%
Revenue YoY
18.8%
Net Profit YoY
148.7%
160.1%
EPS (diluted)
$0.27
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNTB
CNTB
MITK
MITK
Q4 25
$44.2M
Q3 25
$44.8M
Q2 25
$45.7M
Q1 25
$51.9M
Q4 24
$37.3M
Q3 24
$43.2M
Q2 24
$24.1M
$45.0M
Q1 24
$47.0M
Net Profit
CNTB
CNTB
MITK
MITK
Q4 25
$2.8M
Q3 25
$1.9M
Q2 25
$2.4M
Q1 25
$9.2M
Q4 24
$-4.6M
Q3 24
$8.6M
Q2 24
$14.8M
$216.0K
Q1 24
$282.0K
Operating Margin
CNTB
CNTB
MITK
MITK
Q4 25
12.3%
Q3 25
10.5%
Q2 25
8.3%
Q1 25
21.9%
Q4 24
-8.3%
Q3 24
17.8%
Q2 24
56.6%
1.6%
Q1 24
1.5%
Net Margin
CNTB
CNTB
MITK
MITK
Q4 25
6.3%
Q3 25
4.2%
Q2 25
5.2%
Q1 25
17.6%
Q4 24
-12.4%
Q3 24
19.8%
Q2 24
61.6%
0.5%
Q1 24
0.6%
EPS (diluted)
CNTB
CNTB
MITK
MITK
Q4 25
$0.06
Q3 25
$0.04
Q2 25
$0.05
Q1 25
$0.20
Q4 24
$-0.10
Q3 24
$0.19
Q2 24
$0.27
$0.00
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNTB
CNTB
MITK
MITK
Cash + ST InvestmentsLiquidity on hand
$110.2M
$190.1M
Total DebtLower is stronger
$4.8M
Stockholders' EquityBook value
$110.9M
$233.7M
Total Assets
$120.6M
$446.5M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNTB
CNTB
MITK
MITK
Q4 25
$190.1M
Q3 25
$193.0M
Q2 25
$167.1M
Q1 25
$136.2M
Q4 24
$121.2M
Q3 24
$130.3M
Q2 24
$110.2M
$123.1M
Q1 24
$123.9M
Total Debt
CNTB
CNTB
MITK
MITK
Q4 25
$4.8M
Q3 25
$4.3M
Q2 25
Q1 25
Q4 24
Q3 24
$2.7M
Q2 24
Q1 24
Stockholders' Equity
CNTB
CNTB
MITK
MITK
Q4 25
$233.7M
Q3 25
$240.3M
Q2 25
$237.6M
Q1 25
$220.2M
Q4 24
$200.9M
Q3 24
$214.8M
Q2 24
$110.9M
$209.6M
Q1 24
$216.1M
Total Assets
CNTB
CNTB
MITK
MITK
Q4 25
$446.5M
Q3 25
$459.1M
Q2 25
$446.7M
Q1 25
$425.3M
Q4 24
$396.0M
Q3 24
$413.8M
Q2 24
$120.6M
$409.2M
Q1 24
$417.0M
Debt / Equity
CNTB
CNTB
MITK
MITK
Q4 25
0.02×
Q3 25
0.02×
Q2 25
Q1 25
Q4 24
Q3 24
0.01×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNTB
CNTB
MITK
MITK
Operating Cash FlowLast quarter
$-8.0M
$8.0M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
14.9%
Capex IntensityCapex / Revenue
3.2%
Cash ConversionOCF / Net Profit
-0.54×
2.89×
TTM Free Cash FlowTrailing 4 quarters
$60.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNTB
CNTB
MITK
MITK
Q4 25
$8.0M
Q3 25
$19.5M
Q2 25
$21.6M
Q1 25
$13.7M
Q4 24
$565.0K
Q3 24
$21.1M
Q2 24
$-8.0M
$13.0M
Q1 24
$7.1M
Free Cash Flow
CNTB
CNTB
MITK
MITK
Q4 25
$6.6M
Q3 25
$19.2M
Q2 25
$21.2M
Q1 25
$13.5M
Q4 24
$230.0K
Q3 24
$20.8M
Q2 24
$12.6M
Q1 24
$6.6M
FCF Margin
CNTB
CNTB
MITK
MITK
Q4 25
14.9%
Q3 25
42.9%
Q2 25
46.5%
Q1 25
26.0%
Q4 24
0.6%
Q3 24
48.2%
Q2 24
27.9%
Q1 24
14.0%
Capex Intensity
CNTB
CNTB
MITK
MITK
Q4 25
3.2%
Q3 25
0.6%
Q2 25
0.7%
Q1 25
0.4%
Q4 24
0.9%
Q3 24
0.7%
Q2 24
1.0%
Q1 24
1.0%
Cash Conversion
CNTB
CNTB
MITK
MITK
Q4 25
2.89×
Q3 25
10.46×
Q2 25
9.00×
Q1 25
1.50×
Q4 24
Q3 24
2.46×
Q2 24
-0.54×
60.12×
Q1 24
25.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNTB
CNTB

Segment breakdown not available.

MITK
MITK

Fraud And Identity Solutions$25.5M58%
License$13.9M31%
Fraud And Identity Solutions Software License And Support$3.9M9%
Professional Services And Other$1.2M3%

Related Comparisons